SPARC logo

Sun Pharma Advanced Research Company Limited

SPARC·NSE·
₹187.81▼ -0.50 (-0.27%)
Market Cap6122.10 Cr
PE Ratio3.92
Volume3,05,778
Day High - Low190.90 - 186.27
52W High-Low289.00 - 108.00

Sun Pharma Advanced Research Company Limited (SPARC): company summary

The company's business has improved significantly, with annual net profit swinging from a loss of ₹345 crore to a profit of ₹1,553 crore.

Sun Pharma Advanced Research Company Limited (SPARC) is a small-cap Healthcare company valued at ₹6,122 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Sun Pharma Advanced Research Company Limited last traded at ₹187.81, modestly down 0.27% on the day.
Recent developments
On 2026-10-04, Sun Pharma Advanced Research won a ₹28 crore CENVAT credit refund case in CESTAT, which may improve its cash flow and reduce tax liabilities.
Financial performance
The company's business has improved significantly, with annual net profit swinging from a loss of ₹345 crore to a profit of ₹1,553 crore. However, the latest quarter showed a net loss of ₹21 crore, narrowing from a loss of ₹52 crore in the same quarter a year earlier.
Valuation multiples
The stock trades at 3.9 times earnings, a discount to the Healthcare median of 32.0, 4.71 times book value.
Things to watch
The latest quarter reported a net loss of ₹21 crore, which is a concern. The stock is 34.7% below its 52-week high, indicating a significant drop from recent peak levels.
Where it stands
The company has seen a dramatic improvement in annual net profit, but the latest quarter's loss highlights ongoing challenges. The stock's distance below its 52-week high is the most significant figure to note.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
6.2/10
Fair
Fair Value
Sign in to see
ROE
116.20%
Strong
P/E
3.92x
Cheap
Debt / Equity
0.42
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day₹186.27
₹190.90
52W₹108.00
₹289.00
DocStoX take

Supported by valuation (9.0) and quality (6.5), but weakest on growth (4.1).

DocStoX score

Low confidence
6.2
/10
Fair
Quality
Solid
ROE 116.2%
Valuation
Cheap
P/E 3.9×
Growth
Slow
Revenue +49.3% 5Y CAGR
Risk
Moderate
D/E 0.42
Momentum
Soft
44% of 52-week range

At a glance

Market Cap
₹6,122 Cr
52W High / Low
₹289 / ₹108
Dividend Yield
—
Promoter Holding
65.67%
EPS (TTM)
₹47.86
Book Value
₹41.26

Key highlights

  • Strong returns on equity (116%)
  • Capital works hard — ROCE 84%
  • Healthy net margin (83%)
  • Profit shrinking 0% a year
  • Loss-making in some of the last 5 years
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Sun Pharma Advanced Research Company Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.